BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Worthley DL, Whitehall VL, Spring KJ, Leggett BA. Colorectal carcinogenesis: Road maps to cancer. World J Gastroenterol 2007; 13(28): 3784-3791 [PMID: 17657831 DOI: 10.3748/wjg.v13.i28.3784]
URL: https://www.wjgnet.com/1007-9327/full/v13/i28/3784.htm
(0) (0) (13009) (91)
Number Citing Articles
1
A Murata, Y Baba, M Watanabe, H Shigaki, K Miyake, T Ishimoto, M Iwatsuki, S Iwagami, Y Sakamoto, Y Miyamoto, N Yoshida, K Nosho, H Baba. Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. British Journal of Cancer 2013; 109(2) doi: 10.1038/bjc.2013.289
2
Sabha Rasool, Vamiq Rasool, Tahira Naqvi, Bashir A. Ganai, Bhahwal Ali Shah. Genetic unraveling of colorectal cancer. Tumor Biology 2014; 35(6) doi: 10.1007/s13277-014-1713-7
3
Pedro Pinto, Patrícia Rocha, Isabel Veiga, Joana Guedes, Manuela Pinheiro, Ana Peixoto, Carla Pinto, Maria Fragoso, Evaristo Sanches, António Araújo, Fernando Alves, Camila Coutinho, Paula Lopes, Rui Henrique, Manuel R. Teixeira. Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer. Cancer Genetics 2011; 204(8) doi: 10.1016/j.cancergen.2011.07.003
4
Audrey Ferrand. Encyclopedia of Cancer. 2016;  doi: 10.1007/978-3-662-46875-3_6564
5
Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jardé, Simon Wilkins, Gemma Solon, Jeremy D. Shapiro, Helen Abud, Paul McMurrick. Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer. Cancers 2020; 12(4) doi: 10.3390/cancers12040812
6
Mouade El Bali, Joaira Bakkach, Mohcine Bennani Mechita, Alamgeer Yuchi. Colorectal Cancer: From Genetic Landscape to Targeted Therapy. Journal of Oncology 2021; 2021 doi: 10.1155/2021/9918116
7
Emily A Vucic, Carolyn J Brown, Wan L Lam. Epigenetics of Cancer Progression. Pharmacogenomics 2008; 9(2) doi: 10.2217/14622416.9.2.215
8
Paulina Kober, Mateusz Bujko, Janusz Olędzki, Andrzej Tysarowski, Janusz A. Siedlecki. Methyl‐CpG binding column‐based identification of nine genes hypermethylated in colorectal cancer. Molecular Carcinogenesis 2011; 50(11) doi: 10.1002/mc.20763
9
Rehab G. Khalil, Dina A. Mohammed, Hadeer M. Hamdalla, Osama M. Ahmed. The possible anti-tumor effects of regulatory T cells plasticity / IL-35 in the tumor microenvironment of the major three cancer types. Cytokine 2025; 186 doi: 10.1016/j.cyto.2024.156834
10
A. Naccarati, V. Polakova, B. Pardini, L. Vodickova, K. Hemminki, R. Kumar, P. Vodicka. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis 2012; 27(2) doi: 10.1093/mutage/ger067
11
Li Guo, Guowei Yang, Yihao Kang, Sunjing Li, Rui Duan, Lulu Shen, Wenwen Jiang, Bowen Qian, Zibo Yin, Tingming Liang. Construction and Analysis of a ceRNA Network Reveals Potential Prognostic Markers in Colorectal Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00418
12
Albert K. Kwan, Caroline Y. Um, Robin E. Rutherford, March E. Seabrook, Elizabeth L. Barry, Veronika Fedirko, John A. Baron, Roberd M. Bostick. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal‐appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial. Molecular Carcinogenesis 2019; 58(4) doi: 10.1002/mc.22945
13
Xiao-na Chang, Fu-mei Shang, Hong-yu Jiang, Chen Chen, Zhe-yan Zhao, Sheng-he Deng, Jun Fan, Xiao-chuan Dong, Ming Yang, Yan Li, Kai-lin Cai, Li Liu, Hong-li Liu, Xiu Nie. Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China. Current Medical Science 2021; 41(1) doi: 10.1007/s11596-021-2326-1
14
Maria Grazia Cerrito, Emanuela Grassilli. Identifying Novel Actionable Targets in Colon Cancer. Biomedicines 2021; 9(5) doi: 10.3390/biomedicines9050579
15
Xing Chen, Zhu-Hong You, Gui-Ying Yan, Dun-Wei Gong. IRWRLDA: improved random walk with restart for lncRNA-disease association prediction. Oncotarget 2016; 7(36) doi: 10.18632/oncotarget.11141
16
María González-González, María Laura Gutiérrez, José María Sayagués, Luis Muñoz-Bellvís, Alberto Orfao. Genomic profiling of sporadic liver metastatic colorectal cancer. Seminars in Cancer Biology 2021; 71 doi: 10.1016/j.semcancer.2020.05.013
17
Xiyun Deng, Yanna Cao, Yan Liu, Fazhi Li, Kamalanathan Sambandam, Srinivasan Rajaraman, Archibald S. Perkins, Alan P. Fields, Mark R. Hellmich, Courtney M. Townsend, E. Aubrey Thompson, Tien C. Ko. Overexpression of Evi‐1 oncoprotein represses TGF‐β signaling in colorectal cancer. Molecular Carcinogenesis 2013; 52(4) doi: 10.1002/mc.21852
18
Hans Raskov, Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg. Colorectal carcinogenesis-update and perspectives. World Journal of Gastroenterology 2014; 20(48): 18151-18164 doi: 10.3748/wjg.v20.i48.18151
19
Yanglin Zhu, Hong Qin, Kui Ye, Chenglu Sun, Yafei Qin, Guangming Li, Hongda Wang, Hao Wang. Dual role of IL-37 in the progression of tumors. Cytokine 2022; 150 doi: 10.1016/j.cyto.2021.155760
20
Jenia Jenab-Wolcott, Bruce Giantonio. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7 doi: 10.1007/978-1-4614-6015-2_9
21
Eiji Sakai, Ken Ohata, Hideyuki Chiba, Nobuyuki Matsuhashi, Noriteru Doi, Junichi Fukushima, Hiroki Endo, Hirokazu Takahashi, Shingo Tsuji, Koichi Yagi, Keisuke Matsusaka, Hiroyuki Aburatani, Atsushi Nakajima, Atsushi Kaneda. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors. International Journal of Cancer 2014; 135(7) doi: 10.1002/ijc.28814
22
Ramakrishna Vadde, Sridhar Radhakrishnan, Lavanya Reddivari, Jairam K. P. Vanamala. Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio. BioMed Research International 2015; 2015 doi: 10.1155/2015/649263
23
Stefania Marzinotto, Francesca Sessa, Alessandra Franzoni, Alessia Anselmi, Laura Rosa Gastaldo, Silvia Mason, Giuseppe Damante, Carlo Alberto Beltrami, Laura Mariuzzi. KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay. Sequencing 2011; 2011 doi: 10.1155/2011/895709
24
Xiao-Jing Luo, Qi Zhao, Jia Liu, Jia-Bo Zheng, Miao-Zhen Qiu, Huai-Qiang Ju, Rui-Hua Xu. Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer. Molecular Therapy 2021; 29(2) doi: 10.1016/j.ymthe.2020.12.017
25
Veronika Polakova Vymetalkova, Jana Slyskova, Vlasta Korenkova, Ludovit Bielik, Lucie Langerova, Pavel Prochazka, Alexandra Rejhova, Lucie Schwarzova, Barbara Pardini, Alessio Naccarati, Pavel Vodicka. Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients. BMC Medical Genetics 2014; 15(1) doi: 10.1186/1471-2350-15-17
26
Reetu Mukherji, John Marshall, Andreas Seeber. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers 2020; 12(8) doi: 10.3390/cancers12082001
27
Juan Carlos Herrera, Luis Fernando Isaza, José Luis Ramírez, Gonzalo Vásquez, Carlos Mario Muñetón. Detección de aneuploidías del cromosoma 17 y deleción del gen TP53 en una amplia variedad de tumores sólidos mediante hibridación in situ fluorescente bicolor. Biomédica 2010; 30(3) doi: 10.7705/biomedica.v30i3.273
28
Jairam K. P. Vanamala, Aaron R. Massey, Srinivas Rao Pinnamaneni, Lavanya Reddivari, Kenneth F. Reardon. Grain and sweet sorghum (Sorghum bicolorL. Moench) serves as a novel source of bioactive compounds for human health. Critical Reviews in Food Science and Nutrition 2018; 58(17) doi: 10.1080/10408398.2017.1344186
29
Veronika Polakova Vymetalkova, Luca Vannucci, Vlasta Korenkova, Pavel Prochazka, Jana Slyskova, Ludmila Vodickova, Vendula Rusnakova, Ludovit Bielik, Monika Burocziova, Pavel Rossmann, Pavel Vodicka. Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study. Molecular Biology Reports 2013; 40(10) doi: 10.1007/s11033-013-2699-8
30
Aaron R. Massey, Lavanya Reddivari, Jairam Vanamala. The Dermal Layer of Sweet Sorghum (Sorghum bicolor) Stalk, a Byproduct of Biofuel Production and Source of Unique 3-Deoxyanthocyanidins, Has More Antiproliferative and Proapoptotic Activity than the Pith in p53 Variants of HCT116 and Colon Cancer Stem Cells. Journal of Agricultural and Food Chemistry 2014; 62(14) doi: 10.1021/jf405415u
31
Aaron R. Massey, Lavanya Reddivari, Sridhar Radhakrishnan, Venkata Charepalli, Eranda Karunathilake Kurundu Hewage, Vadde Ramakrishna, Jairam K.P. Vanamala. Pro-apoptotic activity against cancer stem cells differs between different parts of sweet sorghum. Journal of Functional Foods 2016; 23 doi: 10.1016/j.jff.2016.03.004
32
Elsa N Garza-Treviño, Salvador L Said-Fernández, Herminia G Martínez-Rodríguez. Understanding the colon cancer stem cells and perspectives on treatment. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0163-7
33
Md Nur Alam, Muhammad Almoyad, Fazlul Huq. Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action. BioMed Research International 2018; 2018 doi: 10.1155/2018/4154185
34
Eduard Sidelnikov, Roberd M. Bostick, W. Dana Flanders, Qi Long, Veronika Fedirko, Aasma Shaukat, Carrie R. Daniel, Robin E. Rutherford. Effects of Calcium and Vitamin D on MLH1 and MSH2 Expression in Rectal Mucosa of Sporadic Colorectal Adenoma Patients. Cancer Epidemiology, Biomarkers & Prevention 2010; 19(4) doi: 10.1158/1055-9965.EPI-09-0526
35
Charuwan Akewanlop, Artit Jinawath, Akarin Nimmannit, Wipawi Klaisuban, Ekkapong Roothumnong, Chanin Limwongse, Ananya Pongpaibul, Krittiya Korphaisarn. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World Journal of Gastroenterology 2015; 21(3): 926-934 doi: 10.3748/wjg.v21.i3.926
36
Carlos Humberto Afanador , Katherine Andrea Palacio , Luis Fernando Isaza , Enoc Ahumada , Carlos Mauricio Ocampo , Carlos Mario Muñetón. Caracterización molecular de pacientes con cáncer colorrectal. Biomédica 2022; 42(Sp. 1) doi: 10.7705/biomedica.5957
37
Maoyu Li, Fang Peng, Guoqing Li, Yang Fu, Ying Huang, Zhuchu Chen, Yongheng Chen. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis. Oncotarget 2016; 7(24) doi: 10.18632/oncotarget.9362
38
María Antonia Lizarbe, Jorge Calle-Espinosa, Eva Fernández-Lizarbe, Sara Fernández-Lizarbe, Miguel Ángel Robles, Nieves Olmo, Javier Turnay. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. BioMed Research International 2017; 2017 doi: 10.1155/2017/7354260
39
Encyclopedia of Cancer. 2011;  doi: 10.1007/978-3-642-16483-5_6564
40
Jian Zhang, Tao Mao, Shuyun Wang, Dongsheng Wang, Zhaojian Niu, Zhenqing Sun, Jianli Zhang. Interleukin-35 expression is associated with colon cancer progression. Oncotarget 2017; 8(42) doi: 10.18632/oncotarget.17751
41
Ayda Pouyafar, Milad Zadi Heydarabad, Sina Bahar Aghdam, Majid Khaksar, Ako Azimi, Reza Rahbarghazi, Mehdi Talebi. Resveratrol potentially increased the tumoricidal effect of doxorubicin on SKOV3 cancer stem cells in vitro. Journal of Cellular Biochemistry 2019; 120(5) doi: 10.1002/jcb.28129
42
Manish Pratap Singh, Sandhya Rai, Ashutosh Pandey, Nand K. Singh, Sameer Srivastava. Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine. Genes & Diseases 2021; 8(2) doi: 10.1016/j.gendis.2019.10.013
43
Ola Marzouk, John Schofield. Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer. Cancers 2011; 3(2) doi: 10.3390/cancers3022767
44
Adrienne C Paterson, Finlay A Macrae, Cathy Pizzey, Graham S Baldwin, Arthur Shulkes. Circulating gastrin concentrations in patients at increased risk of developing colorectal carcinoma. Journal of Gastroenterology and Hepatology 2014; 29(3) doi: 10.1111/jgh.12417
45
Arjen H.G. Cleven, Sarah Derks, Muriel X.G. Draht, Kim M. Smits, Veerle Melotte, Leander Van Neste, Benjamin Tournier, Valerie Jooste, Caroline Chapusot, Matty P. Weijenberg, James G. Herman, Adriaan P. de Bruïne, Manon van Engeland. CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer. Clinical Cancer Research 2014; 20(12) doi: 10.1158/1078-0432.CCR-12-3734
46
Raul D. Bernabe, Ronghua Zhao, Marcia R. Cruz-Correa. Coloproctology. 2010;  doi: 10.1007/978-1-84882-756-1_1
47
Ben George, Scott Kopetz. Predictive and Prognostic Markers in Colorectal Cancer. Current Oncology Reports 2011; 13(3) doi: 10.1007/s11912-011-0162-3
48
Lavanya Reddivari, Venkata Charepalli, Sridhar Radhakrishnan, Ramakrishna Vadde, Ryan J. Elias, Joshua D. Lambert, Jairam K. P. Vanamala. Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis. BMC Complementary and Alternative Medicine 2016; 16(1) doi: 10.1186/s12906-016-1254-2
49
Katharina Ilm, Wolfgang Kemmner, Marc Osterland, Susen Burock, Gudrun Koch, Pia Herrmann, Peter M Schlag, Ulrike Stein. High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0316-2
50
Joanna A. Gibson, Robert D. Odze. Pathology of premalignant colorectal neoplasia. Digestive Endoscopy 2016; 28(3) doi: 10.1111/den.12633
51
Giridhar Mudduluru, Katharina Ilm, Mathias Dahlmann, Ulrike Stein. Mechanisms of Molecular Carcinogenesis – Volume 1. 2017;  doi: 10.1007/978-3-319-53659-0_2
52
Myung-Kyu Jung, Ui Sup Shin, Young-Jun Ki, Yong-Bae Kim, Sun-Mi Moon, Se-Jin Sung. Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer?. Annals of Coloproctology 2017; 33(6) doi: 10.3393/ac.2017.33.6.210
53
Xia Chu, Yiqi Xue, Xinying Huo, Jingsun Wei, Yuetong Chen, Rongbo Han, Hong Chen, Xinyu Su, Honghong Zhang, Yang Gong, Jinfei Chen. Establishment and characterization of a novel cell line (cc‑006cpm8) of moderately/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient. International Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4806
54
A. Benmoussa, S. Zamiati, W. Badre, A. Wakadi, N. Bennani, N. Tahiri Jouti, S. Nadifi. Colorectal cancer: Comparison of clinicopathologic features between Moroccans patients less than 50 years old and older. Pathologie Biologie 2013; 61(3) doi: 10.1016/j.patbio.2012.01.003
55
S. Kansal, A. K. Negi, A. Bhatnagar, N. Agnihotri. Ras Signaling Pathway in the Chemopreventive Action of Different Ratios of Fish Oil and Corn Oil in Experimentally Induced Colon Carcinogenesis. Nutrition and Cancer 2012; 64(4) doi: 10.1080/01635581.2012.675619
56
Avinash Gupta, Wasir Saka, David J Kerr. Personalized medicine in colorectal cancer: the evidence so far. Clinical Investigation 2012; 2(10) doi: 10.4155/cli.12.99
57
Xavier Sagaert. Prognostic biomarkers in colorectal cancer: where do we stand?. Virchows Archiv 2014; 464(3) doi: 10.1007/s00428-013-1532-z
58
Emilio Gil‐Martín, Javier Egea, Russel J. Reiter, Alejandro Romero. The emergence of melatonin in oncology: Focus on colorectal cancer. Medicinal Research Reviews 2019; 39(6) doi: 10.1002/med.21582
59
Deeksha Rikhari, Ankit Srivastava, Sameer Srivastava. Von der Natur inspirierte intelligente Datenverarbeitungstechniken in der Bioinformatik. 2024;  doi: 10.1007/978-981-99-7808-3_4
60
Sandeep Kumar, Bhoomika Sharma, Priyanka Bhadwal, Prerna Sharma, Navneet Agnihotri. Therapeutic Foods. 2018;  doi: 10.1016/B978-0-12-811517-6.00003-9
61
Tae Sung Ahn, Dongjun Jeong, Myoung Won Son, Haeil Jung, Soyoung Park, Hyungjoo Kim, Sang Byung Bae, Han Jo Kim, Young-Woo Jeon, Moon Soo Lee, Moo-Jun Baek. The BRAF mutation is associated with the prognosis in colorectal cancer. Journal of Cancer Research and Clinical Oncology 2014; 140(11) doi: 10.1007/s00432-014-1735-y
62
Chaar Ines, Ounissi Donia, Boughriba Rahma, Azza Ben Ammar, Amara Sameh, Taher Khalfallah, Ben hmida Abdelmajid, Mzabi Sabeh, Bouraoui Saadia. Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort. Tumor Biology 2014; 35(7) doi: 10.1007/s13277-014-1874-4
63
Qi Liao, Weiling He, Jianfa Liu, Yi Cen, Liang Luo, Chengliang Yu, Yang Li, Sitong Chen, Shiwei Duan. Identification and functional annotation of lncRNA genes with hypermethylation in colorectal cancer. Gene 2015; 572(2) doi: 10.1016/j.gene.2015.07.028
64
M. Frattini, G. Gallino, S. Signoroni, D. Balestra, L. Lusa, L. Battaglia, G. Sozzi, L. Bertario, E. Leo, S. Pilotti, M.A. Pierotti. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Letters 2008; 263(2) doi: 10.1016/j.canlet.2008.03.021
65
A. D. Roth, M. Delorenzi, S. Tejpar, P. Yan, D. Klingbiel, R. Fiocca, G. d'Ario, L. Cisar, R. Labianca, D. Cunningham, B. Nordlinger, F. Bosman, E. Van Cutsem. Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer. JNCI Journal of the National Cancer Institute 2012; 104(21) doi: 10.1093/jnci/djs427
66
Audrey Ferrand. Encyclopedia of Cancer. 2015;  doi: 10.1007/978-3-642-27841-9_6564-2
67
Michał Skrzycki, Monika Majewska, Hanna Czeczot. Superoxide dismutase mRNA and protein level in human colorectal cancer. Open Life Sciences 2010; 5(5) doi: 10.2478/s11535-010-0054-9
68
V. Krutovskikh, C. Partensky. Nouvelles perspectives en oncologie : épigénétique et cellules souches cancéreuses. Cancer/Radiothérapie 2011; 15(8) doi: 10.1016/j.canrad.2011.05.012
69
Fang Peng, Ying Huang, Mao-Yu Li, Guo-Qing Li, Hui-Chao Huang, Rui Guan, Zhu-Chu Chen, Song-Ping Liang, Yong-Heng Chen. Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer. World Journal of Gastroenterology 2016; 22(18): 4515-4528 doi: 10.3748/wjg.v22.i18.4515
70
Harrison Sanjay, Benziger Harrison. Colorectal Carcinogenic Pathways and Chemotherapeutic Responsiveness : A Review. Journal Of Digestive Disorders And Diagnosis 2017; 1(2) doi: 10.14302/issn.2574-4526.jddd-16-1321
71
Haoran Bi, Yupeng Liu, Rui Pu, Tingting Xia, Hongru Sun, Hao Huang, Lei Zhang, Yuanyuan Zhang, Ying Liu, Jing Xu, Jiesheng Rong, Yashuang Zhao. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk. Digestive Diseases and Sciences 2019; 64(8) doi: 10.1007/s10620-019-05530-9
72
Nektaria Simiantonaki, Marios Taxeidis, Caren Jayasinghe, Ursula Kurzik-Dumke, Charles James Kirkpatrick. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-320
73
Syed Umesalma, Ganapasam Sudhandiran. Differential Inhibitory Effects of the Polyphenol Ellagic Acid on Inflammatory Mediators NF‐κB, iNOS, COX‐2, TNF‐α, and IL‐6 in 1,2‐Dimethylhydrazine‐Induced Rat Colon Carcinogenesis. Basic & Clinical Pharmacology & Toxicology 2010; 107(2) doi: 10.1111/j.1742-7843.2010.00565.x
74
Vanessa Deschoolmeester, Marc Baay, Pol Specenier, Filip Lardon, Jan B. Vermorken. A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy. The Oncologist 2010; 15(7) doi: 10.1634/theoncologist.2010-0025
75
Nagahide Matsubara. Epigenetic Regulation and Colorectal Cancer. Diseases of the Colon & Rectum 2012; 55(1) doi: 10.1097/DCR.0b013e318233a1ef
76
n-3 PUFAs: an Elixir in Prevention of Colorectal Cancer. Current Colorectal Cancer Reports 2015; 11(3) doi: 10.1007/s11888-015-0268-3
77
Y Liu, G L Borchert, A Surazynski, J M Phang. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 2008; 27(53) doi: 10.1038/onc.2008.322
78
Christophe M. Raynaud, Juana Hernandez, Frédérique P. Llorca, Paolo Nuciforo, Marie-Christine Mathieu, Frederic Commo, Suzette Delaloge, Laure Sabatier, Fabrice André, Jean-Charles Soria. DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer. American Journal of Clinical Oncology 2010; 33(4) doi: 10.1097/COC.0b013e3181b0c4c2
79
Agnieszka B. Bialkowska, Yuhong Du, Haian Fu, Vincent W. Yang. Identification of novel small-molecule compounds that inhibit the proproliferative Krüppel-like factor 5 in colorectal cancer cells by high-throughput screening. Molecular Cancer Therapeutics 2009; 8(3) doi: 10.1158/1535-7163.MCT-08-0767
80
Xiaofei Yan, Jian Zhao, Rui Zhang. Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression. Oncotarget 2017; 8(30) doi: 10.18632/oncotarget.17093
81
Arnaud D. Roth, Sabine Tejpar, Mauro Delorenzi, Pu Yan, Roberto Fiocca, Dirk Klingbiel, Daniel Dietrich, Bart Biesmans, György Bodoky, Carlo Barone, Enrique Aranda, Bernard Nordlinger, Laura Cisar, Roberto Labianca, David Cunningham, Eric Van Cutsem, Fred Bosman. Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial. Journal of Clinical Oncology 2010; 28(3) doi: 10.1200/JCO.2009.23.3452
82
Sabine Tejpar, Monica Bertagnolli, Fred Bosman, Heinz-Joseph Lenz, Levi Garraway, Frederic Waldman, Robert Warren, Andrea Bild, Denise Collins-Brennan, Hejin Hahn, D. Paul Harkin, Richard Kennedy, Mohammad Ilyas, Hans Morreau, Vitali Proutski, Charles Swanton, Ian Tomlinson, Mauro Delorenzi, Roberto Fiocca, Eric Van Cutsem, Arnaud Roth. Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery. The Oncologist 2010; 15(4) doi: 10.1634/theoncologist.2009-0233
83
Peizhuang Zhao, Jiajia Ning, Jun Huang, Binqian Wei, Zhen Wang, Xue Huang. High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma. International Journal of General Medicine 2023;  doi: 10.2147/IJGM.S420715
84
Talha Bader, Abdelsalam Ismail. Higher prevalence of KRAS mutations in colorectal cancer in Saudi Arabia: Propensity for lung metastasis. Alexandria Journal of Medicine 2014; 50(3) doi: 10.1016/j.ajme.2014.01.003
85
Adam I. Cygankiewicz, Damian Jacenik, Wanda M. Krajewska. Introduction to Gastrointestinal Diseases Vol. 2. 2017;  doi: 10.1007/978-3-319-59885-7_11
86
E. Tulupova, R. Kumar, M. Hanova, J. Slyskova, B. Pardini, V. Polakova, A. Naccarati, L. Vodickova, J. Novotny, J. Halamkova, K. Hemminki, P. Vodicka. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2008; 648(1-2) doi: 10.1016/j.mrfmmm.2008.09.005
87
A S Strimpakos, K N Syrigos, M W Saif. Pharmacogenetics and biomarkers in colorectal cancer. The Pharmacogenomics Journal 2009; 9(3) doi: 10.1038/tpj.2009.8
88
Vid Mlakar, Gašper Berginc, Metka Volavšek, Zdravko Štor, Miran Rems, Damjan Glavač. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-282
89
Deeksha Rikhari, Ankit Srivastava, Sameer Srivastava. Nature-Inspired Intelligent Computing Techniques in Bioinformatics. Studies in Computational Intelligence 2023; 1066 doi: 10.1007/978-981-19-6379-7_4
90
Raju Suresh Kumar, Abdulrahman I. Almansour, Natarajan Arumugam. In vitro mechanistic investigation of polycyclic cage-like heterocyclic hybrid possessing diverse pharmacophoric units. Journal of King Saud University - Science 2020; 32(4) doi: 10.1016/j.jksus.2020.03.029
91
Samer Alzoubi, Leigh Brody, Sunniyat Rahman, Anne-Laure Mahul-Mellier, Nicolas Mercado, Kazuhiro Ito, Mona El-Bahrawy, Andrew Silver, Alan Boobis, Jimmy D. Bell, Nabil Hajji. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget 2016; 7(28) doi: 10.18632/oncotarget.9887
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.